Krystal Biotech Files 8-K on Officer/Director Changes
Ticker: KRYS · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, financial-reporting
TL;DR
Krystal Biotech 8-K: Leadership changes and financial updates filed Dec 23, 2025.
AI Summary
Krystal Biotech, Inc. filed an 8-K on December 23, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and governance, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing leadership changes and financial statements, not indicating immediate operational or financial distress.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- December 23, 2025 (date) — Date of earliest event reported
- 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203 (address) — Principal executive offices
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
Are there any new compensatory arrangements for officers detailed in this filing?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specifics of these arrangements are not provided in the excerpt.
What is the primary business of Krystal Biotech, Inc. according to the filing?
Krystal Biotech, Inc. is in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' industry, SIC code 2836.
When was this 8-K form filed?
This Form 8-K was filed on December 23, 2025.
What is the state of incorporation for Krystal Biotech, Inc.?
Krystal Biotech, Inc. is incorporated in Delaware.
Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-23 16:51:08
Filing Documents
- krys-20251223.htm (8-K) — 32KB
- 0001711279-25-000092.txt ( ) — 136KB
- krys-20251223.xsd (EX-101.SCH) — 2KB
- krys-20251223_lab.xml (EX-101.LAB) — 20KB
- krys-20251223_pre.xml (EX-101.PRE) — 11KB
- krys-20251223_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data file (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 23, 2025 KRYSTAL BIOTECH, INC. By: /s/ Krish S. Krishnan Name: Krish S. Krishnan Title: Chairman and Chief Executive Officer